Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
VIDAS Varicella Zoster IgG (VZG) antibody IVD Recalled by bioMerieux, Inc. Due to Two batches of VIDAS Varicella-Zoster IgG (VZG ref...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact bioMerieux, Inc. directly.
Affected Products
VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit
Quantity: 1,218 US units total (726 US, 492 OUS)
Why Was This Recalled?
Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result.
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About bioMerieux, Inc.
bioMerieux, Inc. has 53 total recalls tracked by RecallDetector.
Related Recalls
EndoVive Safety PEG Kit Recalled by Boston Scientific Corporation Due to Recall of kits which utilized ChloraPrep Triple Swabsticks...
Boston Scientific Corporation · February 10, 2026
Owner's Booklets and Instructions for Use that are used with Recalled by Trividia Health, Inc. Due to The system labeling (user manual and online labeling)...
Trividia Health, Inc. · February 6, 2026
Artelon FlexBand Dynamic Matrix Ref: 31057 Recalled by International Life Sciences Due to Augmentation devices failed bacterial endotoxin testing.
International Life Sciences · February 6, 2026
Owner's Booklets and Instructions for Use that are used with Recalled by Trividia Health, Inc. Due to The system labeling (user manual and online labeling)...
Trividia Health, Inc. · February 6, 2026
Owner's Booklets and Instructions for Use that are used with Recalled by Trividia Health, Inc. Due to The system labeling (user manual and online labeling)...
Trividia Health, Inc. · February 6, 2026
Data sourced from the FDA (Device). Last updated March 26, 2026. View original report